InsiderDB

SEC EDGAR · Company announcement

INM: Other company developments

Filed 8-K for an event or period dated 2026-11-04. Other company developments.

Follow INM
Became public
Nov 5, 2026, 6:04 AM EST
Event / period date
Nov 4, 2026
Collected
Nov 16, 2026, 7:07 AM EST

Why this is connected

This filing identifies InMed Pharmaceuticals Inc. as the issuer of the security. The company's SEC identifier connects it to INM.

Press Release dated November 4, 2026. ↗

Source evidence

Read the source excerpt or record
Item 8.01. Other Events. On November 4, 2026, the Company issued a press release announcing the results of its Shareholders Meeting, the Name Change and the completion of the Consolidation. The completion of the Consolidation resulted in the Common Shares being reduced from 5,493,735 to approximately 549,374 Common Shares on a non-diluted basis, and each shareholder holds the same percentage of Common Shares outstanding immediately after the Consolidation as such shareholder held immediately prior to the Consolidation. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The press release contains forward-looking statements and includes cautionary statements identifying important factors that could cause actual results to differ materially from those in the forward-looking statements. In addition to the Consolidation, and as described in greater detail in Item 5.03 of this Current Report, the Company’s Name Change became legally effective as of November 4, 2026, in connection with the expected closing of the Merger. The information set forth in Item 5.03 is hereby incorporated into this Item 8.01 by reference. In connection with the Merger and pursuant to a contingent value rights agreement to be entered into on or prior to the Closing Date (the “CVR Agreement”), the Company expects to issue to shareholders of record as of the close of business on November 5, 2026 (the “CVR Distribution Record Date”) one contingent value right (each, a “CVR”) for each outstanding Common Share held by such shareholder as of the CVR Distribution Record Date on a post-Consolidation basis, with each CVR representing the right to receive contingent payments upon the occurrence of certain events set forth in, and subject to and in accordance 

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.